dr. choueiri on savolitinib in papillary renal cell cancer
Published 7 years ago • 408 plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
2:46
dr. choueiri on results of the savoir trial in met-driven papillary rcc
-
6:13
dr toni choueiri discusses a phase 2 clinical trial on volitinib in papillary renal cell carcinoma
-
0:41
dr. toni choueiri on cabozantinib and nivolumab combination in kidney cancer
-
0:52
dr. choueiri on impact of cabosun results in renal cell carcinoma
-
2:16
savolitinib plus durvalumab show promise in papillary renal cancer: calypso results
-
1:35
dr. toni choueiri on cabozantinib versus everolimus in renal cell carcinoma
-
0:52
dr. choueiri on the role of cabozantinib in rcc
-
2:13
dr. choueiri on existing therapies for kidney cancer
-
2:17
dr. choueiri on the role of traditional agents in kidney cancer
-
1:06
dr. choueiri on atezolizumab plus bevacizumab in non–clear cell rcc
-
1:44
dr. choueiri on cabosun trial results in rcc
-
2:31
toni choueiri, md, describes treatment strategies for 2nd line renal cell carcinoma
-
5:21
asco: savolitinib for patients with met-driven papillary renal cell carcinoma
-
1:08
dr. choueiri on the biology of the cabosun trial for rcc
-
1:39
dr. linehan on gene mutations in papillary kidney cancer
-
0:45
dr. choueiri on fda approval of lenvatinib/everolimus in rcc
-
2:16
highlights in renal cell carcinoma - dr. toni choueiri
-
1:43
dr. choueiri on checkpoint inhibitors to treat sarcomatoid carcinoma
-
1:20
dr. choueiri on overall findings of cabosun trial for rcc